Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 667  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Article Submission Resources Sections Etcetera Contact
 
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

Use of recombinant factor VIIa for emergency reversal of anticoagulation

Ingerslev J, Vanek T, Culic S

Year : 2007| Volume: 53| Issue : 1 | Page no: 17-22

   This article has been cited by
 
1 Surgical Management of Severe Spontaneous Hemorrhage of the Abdominal Wall Complicating Acenocoumarol Treatment
Orestis Ioannidis,George Paraskevas,Anastasios Kotronis,Stavros Chatzopoulos,Athina Konstantara,Nikolaos Papadimitriou,Apostolos Makrantonakis,Emmanouil Kakoutis
Acta Medica (Hradec Kralove, Czech Republic). 2015; 55(1): 47
[Pubmed]  [Google Scholar] [DOI]
2 Rapid Reversal of Warfarin-Associated Hemorrhage in the Emergency Department by Prothrombin Complex Concentrates
Kenneth Frumkin
Annals of Emergency Medicine. 2013;
[Pubmed]  [Google Scholar] [DOI]
3 Guideline on the management of bleeding in patients on antithrombotic agents
Mike Makris,Joost J. Van Veen,Campbell R. Tait,Andrew D. Mumford,Mike Laffan
British Journal of Haematology. 2013; 160(1): 35
[Pubmed]  [Google Scholar] [DOI]
4 Anticoagulation-Related Intracranial Hemorrhages
Manoj K. Mittal,Alejandro A. Rabinstein
Current Atherosclerosis Reports. 2012; 14(4): 351
[Pubmed]  [Google Scholar] [DOI]
5 Medical Care of Patients With Brain Tumors
Jan Drappatz
CONTINUUM: Lifelong Learning in Neurology. 2012; 18: 275
[Pubmed]  [Google Scholar] [DOI]
6 A review of current methods for assessing hemostasis in vivo and introduction to a potential alternative approach
Mallory R. Scola,Leslie M. Baggesen,Tim C. Nichols,Nigel S. Key,Caterina M. Gallippi
Thrombosis Research. 2012; 129: S57
[Pubmed]  [Google Scholar] [DOI]
7 Protamine reversal of low molecular weight heparin : clinically effective?
Joost J. van Veen, Rhona M. Maclean, Kingsley K. Hampton, Stuart Laidlaw, Steve Kitchen, Peter Toth, Mike Makris
Blood Coagulation & Fibrinolysis. 2011; 22(7): 565
[HTML Full text]  [Google Scholar] [DOI]
8 Prophylactic correction of the international normalized ratio in neurosurgery: a brief review of a brief literature : A review
Kelly L. West, Cory Adamson, Maureane Hoffman
Journal of Neurosurgery. 2011; 114(1): 9-18
[Pubmed]  [Google Scholar] [DOI]
9 The practical management of intracerebral hemorrhage associated with oral anticoagulant therapy : Review
International Journal of Stroke. 2011; : no
[HTML Full text]  [Google Scholar] [DOI]
10
Adriana Cajiao
Journal of Medical and Biological Engineering. 2011; 31(2): 129
[HTML Full text]  [Google Scholar] [DOI]
11 Use of recombinant factor VIIa (NovoSeven<sup>®</sup>) in 8 patients with ongoing life-threatening bleeding treated with fondaparinux : Pharmacology
Acute Cardiac Care. 2011; 13(2): 93
[HTML Full text]  [Google Scholar] [DOI]
12 Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: a randomized study : PCC for oral anticoagulant reversal in CPB surgery
R. Demeyere, S. Gillardin, J. Arnout, P. F. W. Strengers
Vox Sanguinis. 2010; 99(3): 251-260
[Pubmed]  [Google Scholar] [DOI]
13 Newer antithrombotic drugs
Sikka, P., Bindra, V.K.
Indian Journal of Critical Care Medicine. 2010; 14(4): 188-195
[Pubmed]  [Google Scholar]
14 Gastrointestinal Bleeding in the Setting of Anticoagulation and Antiplatelet Therapy
Kassem Barada,Heitham Abdul-Baki,Ihab I. El Hajj,Jana G. Hashash,Peter H. Green
Journal of Clinical Gastroenterology. 2009; 43(1): 5
[Pubmed]  [Google Scholar] [DOI]
15 The role of recombinant-activated factor VII in bleeding trauma patients
Richard P Dutton,Bianca M Conti
Current Opinion in Anaesthesiology. 2009; 22(2): 299
[Pubmed]  [Google Scholar] [DOI]
16 Gastrointestinal Bleeding in the Setting of Anticoagulation and Antiplatelet Therapy.
Barada, K. and Abdul-Baki, H. and El Hajj, I.I. and Hashash, J.G. and Green, P.H.
Journal of Clinical Gastroenterology. 2009; 43(1): 5-12
[Pubmed]  [Google Scholar]
17 How to reverse an antithrombotic agent
Neuner, M., Davis, J.
Emergency Medicine. 2009; 41(6)
[Pubmed]  [Google Scholar]
18 The role of recombinant-activated factor VII in bleeding trauma patients
Dutton, R.P., Conti, B.M.
Current Opinion in Anaesthesiology. 2009; 22(2): 299-304
[Pubmed]  [Google Scholar]
19 Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment
Walter Ageno,David Garcia,Maria I. Aguilar,James Douketis,Guido Finazzi,Davide Imberti,Alfonso Iorio,Nigel S. Key,Wendy Lim,Marco Marietta,Domenico Prisco,Ravi Sarode,Sophie Testa,Alberto Tosetto,Mark Crowther
American Journal of Hematology. 2009; 84(9): 584
[Pubmed]  [Google Scholar] [DOI]
20 Use of recombinant activated factor VII | [Rekombinantinio aktyvinto VII krešėjimo faktoriaus vartojimas]
Reingardiene, D., Lažauskas, R.
Medicina. 2009; 45(3): 248-253
[Pubmed]  [Google Scholar]
21 Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 2: Treatment
Ageno, W., Garcia, D., Aguilar, M.I., Douketis, J., Finazzi, G., Imberti, D., Iorio, A., Crowther, M.
American Journal of Hematology. 2009; 84(9): 584-588
[Pubmed]  [Google Scholar]
22 Coagulation factor VIIa (recombinant) in nonhemophilic patients requiring neurosurgery
Culley, C.M., Guttendorf, S., Coldren, M., Skledar, S.J., Gross, P.R., Spiro, R.M., Triulzi, D.J., Ragni, M.V.
American Journal of Health-System Pharmacy. 2009; 66(17): 1554-1559
[Pubmed]  [Google Scholar]
23 What Is the Evidence for the Off-label Use of Recombinant Factor VIIa (rFVIIa) in the Acute Reversal of Warfarin?
R. P. Rosovsky,M. A. Crowther
Hematology. 2008; 2008(1): 36
[Pubmed]  [Google Scholar] [DOI]
24 Perioperative Hemostatic Management of Patients Treated with Vitamin K Antagonists
Jerrold H. Levy,Kenichi A. Tanaka,Wulf Dietrich
Anesthesiology. 2008; 109(5): 918
[Pubmed]  [Google Scholar] [DOI]
25 Use of rFVIIa in two children presenting major bleeding not controlled by the usual treatments before emergent surgery
Eliane Guyot,Aude Carillion,Marie-Laurence Poli-Mérol,Isabelle Ferrand,Philippe Chauvet,Philippe Nguyen,Jean-Marc Malinovsky
Pediatric Anesthesia. 2008; 18(12): 1226
[Pubmed]  [Google Scholar] [DOI]
26 Polyphosphate as a general procoagulant agent
S. A. SMITH,J. H. MORRISSEY
Journal of Thrombosis and Haemostasis. 2008; 6(10): 1750
[Pubmed]  [Google Scholar] [DOI]
27 On-Label Versus Off-Label Use of Recombinant Activated Factor VII: A Comprehensive Review of Use in Two Canadian Centers
Manuel D. Carcao,Kathryn E. Webert
Seminars in Hematology. 2008; 45: S68
[Pubmed]  [Google Scholar] [DOI]
28 On-label versus off-label use of recombinant activated factor VII: A comprehensive review of use in two Canadian centers
Carcao MD, Webert KE
SEMINARS IN HEMATOLOGY. 2008; 45((SUPPL 1)): S68-S71
[Pubmed]  [Google Scholar]
29 Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats
U. HEDNER, P. B. JOHANSEN, M. TRANHOLM, M. EZBAN, B. LAURITZEN
Journal of Thrombosis and Haemostasis. 2008; 6(5): 804-811
[Pubmed]  [Google Scholar] [DOI]
30 Perioperative Hemostatic Management of Patients Treated with Vitamin K Antagonists
Levy, J.H. and Tanaka, K.A. and Dietrich, W.
Anesthesiology. 2008; 109(5): 918-926
[Pubmed]  [Google Scholar]
31 What Is the Evidence for the Off-label Use of Recombinant Factor VIIa (rFVIIa) in the Acute Reversal of Warfarin?
Rosovsky, R.P. and Crowther, M.A.
Hematology. 2008; 2008(1): 36
[Pubmed]  [Google Scholar]
32 Polyphosphate as a general procoagulant agent
Smith, SA and Morrissey, JH
Journal of Thrombosis and Haemostasis. 2008; 6(10): 1750-1756
[Pubmed]  [Google Scholar]
33 Use of rFVIIa in two children presenting major bleeding not controlled by the usual treatments before emergent surgery
Guyot, E. and Carillion, A. and Poli-Merol, M.L. and Ferrand, I. and Chauvet, P. and Nguyen, P. and Malinovsky, J.M.
Pediatric Anesthesia. 2008; 18(12): 1226-1228
[Pubmed]  [Google Scholar]
34 Medical management of brain tumor patients
Drappatz J, Schiff D, Kesarl S, et al.
NEUROLOGIC CLINICS. 2007; 25 (4): 1035-1071
[Pubmed]  [Google Scholar]
35 Emergency correction of coagulation before major surgery in two elderly patients on oral anticoagulation
Angelo, M. and Gutmann, B. and Adami, M. and Zagler, B. and Zelger, A. and Pechlaner, C. and Wiedermann, C.J.
Thrombosis Journal. 2007; 5(1): 1
[Pubmed]  [Google Scholar]
36 Medical Management of Brain Tumor Patients
Jan Drappatz,David Schiff,Santosh Kesari,Andrew D. Norden,Patrick Y. Wen
Neurologic Clinics. 2007; 25(4): 1035
[Pubmed]  [Google Scholar] [DOI]
37 Pharmacologic Interventions for the Management of Critical Bleeding
Stacy Voils
Pharmacotherapy. 2007; 27(9 part 2): 69S
[HTML Full text]  [Google Scholar] [DOI]
38 Rapid reversal of anticoagulant bleeding- rFVIIa an option?
Zupancic-Salek, S.
Journal of Postgraduate Medicine. 2007; 53(1): 3-4
[Pubmed]  [Google Scholar]
39 Factor VIIa: Mounting evidence or anecdotal reports
MacLaren, R.
Journal of Postgraduate Medicine. 2007; 53(1): 4-5
[Pubmed]  [Google Scholar]

 

Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow